CELLDOM, INC
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to tens of thousands of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology.
CELLDOM, INC
Industry:
Biotechnology Genetics Health Care Life Science
Founded:
2016-02-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.celldom.com
Total Employee:
1+
Status:
Active
Contact:
267-971-7239
Email Addresses:
[email protected]
Total Funding:
1.95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Euro
Similar Organizations
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
TSVC
TSVC investment in Seed Round - Celldom, Inc
Life Science Angels
Life Science Angels investment in Venture Round - Celldom, Inc
National Institutes of Health
National Institutes of Health investment in Grant - Celldom, Inc
National Institutes of Health
National Institutes of Health investment in Grant - Celldom, Inc
Official Site Inspections
http://www.celldom.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Celldom, Inc"
Celldom, Inc - Crunchbase Company Profile & Funding
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. …See details»
Celldom
The Celldom platform collects a full range of molecular and functional readouts from each cell under standard culture conditions across hours or days. These readouts include detection of …See details»
Celldom, Inc. - LinkedIn
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations.See details»
Celldom - The Org
Celldom is developing next-generation, high throughput single-cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. …See details»
Celldom 2025 Company Profile: Valuation, Funding & Investors
Who are Celldom’s investors? BioTools Innovator, MedTech Innovator, Life Science Angels, Paeonia Group, and Red Forest Capital are 5 of 10 investors who have invested in Celldom. …See details»
Celldom Company Profile - Office Locations, Competitors ... - Craft
Celldom has 5 employees across 2 locations and $2 m in total funding,. See insights on Celldom including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Celldom, Inc. Company Profile | San Carlos, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Celldom, Inc. of San Carlos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Celldom, Inc - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Exec Bios — Celldom
In 2015, Dr. Tkachenko established MuWells, a microfluidic foundry, and was its CEO until the company merged with Celldom in 2022. Under his leadership, MuWells has completed more …See details»
Celldom, Inc. - VentureRadar
Celldom has developed a platform for massively parallel pharmacogenomics to computerize biology by unmasking cellular heterogeneity. This platform has immediate touch-points in drug …See details»
Celldom - Products, Competitors, Financials, Employees, …
Celldom to Tackle Single-Cell Analysis Sector with Integrated Genotyping, Phenotyping Platform. Sep 20, 2018. Premium NEW YORK (GenomeWeb) – Fresh off receiving a $1.5 million Small …See details»
Celldom, Inc - Contacts, Employees, Board Members ... - Crunchbase
Organization. Celldom, Inc . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Celldom - Overview, News & Similar companies | ZoomInfo.com
Sep 11, 2018 Who is Celldom. Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by …See details»
celldom Company Information - Funding, Investors, and More
Celldom is a single cell omics company founded in 2016 by Zach Forbes, Benjamin Yellen and Kris Wood. Seedtable Score 76 Startups. 4. Funding Rounds. $2.0m. Money raised. About; …See details»
celldom - Golden
Celldom. celldom is a single cell omics company founded in 2016 by Zach Forbes, Benjamin Yellen and Kris Wood. Overview Structured Data Issues Contributors Activity. Contents. …See details»
Celldom | Seed
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https ... The Celldom consumable contains …See details»
CellDom, Inc — Duke OTC
High throughput screening that allows the manipulation of single cells We are massively parallel single cell pharmacogenomics. Gordon Moore once said that if the auto industry advanced as …See details»
Celldom: Leading the Next Generation Single-Cell Analysis
Given the significant market potential and recent successful IPOs by companies like 10X Genomics ($21B) and Berkeley Lights ($5B), Celldom is poised for success. Compared to 10X …See details»
Firm | SBIR
High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity. Amount: $1,480,039 Topic: 300 ABSTRACT Celldom is developing a high …See details»
Celldom Aims to Ease Cell Therapy Potency Assay Challenges With …
May 16, 2024 Celldom is commercializing an instrument to more easily, directly, and quickly measure cell therapy potency. The instrument combines imaging-based phenotyping with …See details»